Clinical Trial Update: Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of fexinidazole for human African trypanosomiasis evaluating safety, tolerability, and pharmacokinetics with a loading dose and with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African | Phase 1 | Status: TERMINATED